chr9-35065348-G-A
Variant summary
Our verdict is Likely pathogenic. The variant received 6 ACMG points: 6P and 0B. PM1PM2PM5
The NM_007126.5(VCP):c.479C>T(p.Ala160Val) variant causes a missense change involving the alteration of a conserved nucleotide. The variant was absent in control chromosomes in GnomAD project. Variant has been reported in ClinVar as Uncertain significance (★). Another variant affecting the same amino acid position, but resulting in a different missense (i.e. A160P) has been classified as Likely pathogenic.
Frequency
Consequence
NM_007126.5 missense
Scores
Clinical Significance
Conservation
Publications
- complex neurodevelopmental disorderInheritance: AD Classification: DEFINITIVE Submitted by: Ambry Genetics
- inclusion body myopathy with Paget disease of bone and frontotemporal dementiaInheritance: AD Classification: DEFINITIVE, SUPPORTIVE Submitted by: ClinGen, Orphanet
- Charcot-Marie-Tooth disease type 2YInheritance: AD Classification: STRONG, SUPPORTIVE Submitted by: Orphanet, Labcorp Genetics (formerly Invitae)
- frontotemporal dementia and/or amyotrophic lateral sclerosis 6Inheritance: AD Classification: STRONG Submitted by: Genomics England PanelApp, Labcorp Genetics (formerly Invitae)
- inclusion body myopathy with Paget disease of bone and frontotemporal dementia type 1Inheritance: AD Classification: STRONG Submitted by: Labcorp Genetics (formerly Invitae)
- adult-onset distal myopathy due to VCP mutationInheritance: AD Classification: SUPPORTIVE Submitted by: Orphanet
- amyotrophic lateral sclerosisInheritance: AD Classification: SUPPORTIVE Submitted by: Orphanet
- frontotemporal dementia with motor neuron diseaseInheritance: AD Classification: SUPPORTIVE Submitted by: Orphanet
- spastic paraplegia-Paget disease of bone syndromeInheritance: AD Classification: SUPPORTIVE Submitted by: Orphanet
- neurodevelopmental disorderInheritance: AD Classification: LIMITED Submitted by: G2P
Genome browser will be placed here
ACMG classification
Our verdict: Likely_pathogenic. The variant received 6 ACMG points.
Transcripts
RefSeq
| Gene | Transcript | HGVSc | HGVSp | Effect | Exon rank | MANE | Protein | UniProt |
|---|---|---|---|---|---|---|---|---|
| VCP | NM_007126.5 | c.479C>T | p.Ala160Val | missense_variant | Exon 5 of 17 | ENST00000358901.11 | NP_009057.1 | |
| VCP | NM_001354927.2 | c.344C>T | p.Ala115Val | missense_variant | Exon 5 of 17 | NP_001341856.1 | ||
| VCP | NM_001354928.2 | c.344C>T | p.Ala115Val | missense_variant | Exon 5 of 17 | NP_001341857.1 |
Ensembl
| Gene | Transcript | HGVSc | HGVSp | Effect | Exon rank | TSL | MANE | Protein | Appris | UniProt |
|---|---|---|---|---|---|---|---|---|---|---|
| VCP | ENST00000358901.11 | c.479C>T | p.Ala160Val | missense_variant | Exon 5 of 17 | 1 | NM_007126.5 | ENSP00000351777.6 | ||
| ENSG00000288699 | ENST00000681845.1 | n.*577C>T | non_coding_transcript_exon_variant | Exon 5 of 5 | ENSP00000505452.1 | |||||
| ENSG00000288699 | ENST00000681845.1 | n.*577C>T | 3_prime_UTR_variant | Exon 5 of 5 | ENSP00000505452.1 |
Frequencies
GnomAD3 genomes Cov.: 32
GnomAD4 exome Cov.: 31
GnomAD4 genome Cov.: 32
ClinVar
Submissions by phenotype
Inclusion body myopathy with Paget disease of bone and frontotemporal dementia;C5436279:Frontotemporal dementia and/or amyotrophic lateral sclerosis 6 Uncertain:1
This sequence change replaces alanine, which is neutral and non-polar, with valine, which is neutral and non-polar, at codon 160 of the VCP protein (p.Ala160Val). This variant is not present in population databases (gnomAD no frequency). This variant has not been reported in the literature in individuals affected with VCP-related conditions. ClinVar contains an entry for this variant (Variation ID: 532758). Advanced modeling of protein sequence and biophysical properties (such as structural, functional, and spatial information, amino acid conservation, physicochemical variation, residue mobility, and thermodynamic stability) performed at Invitae indicates that this missense variant is not expected to disrupt VCP protein function with a negative predictive value of 80%. This variant disrupts the p.Ala160 amino acid residue in VCP. Other variant(s) that disrupt this residue have been determined to be pathogenic (PMID: 28692196, 29754758; Invitae). This suggests that this residue is clinically significant, and that variants that disrupt this residue are likely to be disease-causing. In summary, the available evidence is currently insufficient to determine the role of this variant in disease. Therefore, it has been classified as a Variant of Uncertain Significance. -
Computational scores
Source:
Splicing
Find out detailed SpliceAI scores and Pangolin per-transcript scores at